We publish news of technology innovations, investment opportunities, together with updates from spin-out & start-up companies and licensees
Oxford Innovation Society has a dynamic new programme, expanding global investor connections and fostering deeper industry collaborations.
Oxford spinout BioFragment won a Chemovator prize at Stage Two, Europe’s largest university startup pitch, boosting their mission to revolutionise drug discovery with sustainable biocatalysis.
Oxford University Innovation (OUI) has made significant strides in research commercialisation, creating over 300 spinout companies based on research and ideas from students, staff, and alumni. Many of these companies are based on patented Intellectual Property (IP)and software from University of Oxford labs.
adh_we, a startup from the Oxford University Innovation incubator, pioneers neuro-inclusive consumer experiences.
The University of Oxford and the Ellison Institute of Technology (EIT) have formed a strategic alliance, backed by a minimum £130 million investment from EIT, to accelerate innovation and address some of the world’s most pressing challenges.
Oxford University and Oxford University Innovation joined founders, investors and other universities to throw their weight behind the Government’s bid to boost growth by converting more of the UK’s world-leading research into successful companies.
Oxford Venture Scouts was set up for founders looking to access world-leading scientific teams and bring that science to market.
Oxford University Innovation’s impact report highlights its 12-month results including £872m of investment, and the creation of 15 new companies.
A powerful new tool - launched by the Ellison Institute of Technology (EIT) – is demonstrative of the impact of university research on global health.
Vasculitis is a complex and unpredictable disease, primarily caused by inflammation of the blood vessels.
